JPWO2022255349A1 - - Google Patents
Info
- Publication number
- JPWO2022255349A1 JPWO2022255349A1 JP2023525850A JP2023525850A JPWO2022255349A1 JP WO2022255349 A1 JPWO2022255349 A1 JP WO2022255349A1 JP 2023525850 A JP2023525850 A JP 2023525850A JP 2023525850 A JP2023525850 A JP 2023525850A JP WO2022255349 A1 JPWO2022255349 A1 JP WO2022255349A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021091607 | 2021-05-31 | ||
| PCT/JP2022/022077 WO2022255349A1 (ja) | 2021-05-31 | 2022-05-31 | 可溶型ｃｌｅｃ２を用いた出血性脳卒中のリスク評価法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022255349A1 true JPWO2022255349A1 (https=) | 2022-12-08 |
| JPWO2022255349A5 JPWO2022255349A5 (https=) | 2025-03-21 |
Family
ID=84323410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525850A Pending JPWO2022255349A1 (https=) | 2021-05-31 | 2022-05-31 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240264175A1 (https=) |
| EP (1) | EP4350350A4 (https=) |
| JP (1) | JPWO2022255349A1 (https=) |
| KR (1) | KR20240017001A (https=) |
| CN (1) | CN117769652A (https=) |
| WO (1) | WO2022255349A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025075139A1 (ja) * | 2023-10-06 | 2025-04-10 | Ｐｈｃ株式会社 | 可溶型ｃｌｅｃ－２を用いた脳心血管・腎イベントの長期的発症ハイリスク評価法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6078845U (ja) | 1983-11-04 | 1985-06-01 | ライオン株式会社 | 食用廃油固化処理用具 |
| AU2002359815A1 (en) * | 2001-12-19 | 2003-07-09 | Immunex Corporation | C-type lectin polypeptide, polynucleotide and methods of making and use thereof |
| JP6078845B2 (ja) * | 2012-09-28 | 2017-02-15 | 株式会社Ｌｓｉメディエンス | 可溶型ｃｌｅｃ−２に基づく血小板活性化測定方法 |
| US10227407B2 (en) * | 2013-10-10 | 2019-03-12 | Yukinari Kato | Anti-podoplanin antibody |
| JP7172286B2 (ja) | 2018-08-28 | 2022-11-16 | スズキ株式会社 | ニーエアバッグ取付け構造 |
| JP6883348B2 (ja) | 2019-06-26 | 2021-06-09 | 稔 甲斐 | 閉塞防止機能付振動篩用網及び振動篩装置 |
| EP4113524A4 (en) * | 2020-02-28 | 2024-03-06 | LSI Medience Corporation | METHOD FOR MEASURING PLATELE ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELE COUNT |
-
2022
- 2022-05-31 EP EP22816095.8A patent/EP4350350A4/en active Pending
- 2022-05-31 JP JP2023525850A patent/JPWO2022255349A1/ja active Pending
- 2022-05-31 KR KR1020237044828A patent/KR20240017001A/ko active Pending
- 2022-05-31 CN CN202280038986.4A patent/CN117769652A/zh active Pending
- 2022-05-31 WO PCT/JP2022/022077 patent/WO2022255349A1/ja not_active Ceased
- 2022-05-31 US US18/565,258 patent/US20240264175A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240017001A (ko) | 2024-02-06 |
| WO2022255349A1 (ja) | 2022-12-08 |
| EP4350350A1 (en) | 2024-04-10 |
| US20240264175A1 (en) | 2024-08-08 |
| CN117769652A (zh) | 2024-03-26 |
| EP4350350A4 (en) | 2025-04-30 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250312 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250312 |